Financial Performance - The group's revenue increased from approximately RMB 324.2 million for the year ended December 31, 2021, to approximately RMB 356.7 million for the year ended December 31, 2022, representing a growth of 10.0%[2] - The adjusted profit for the year ended December 31, 2022, was approximately RMB 66.3 million, down from RMB 92.6 million for the year ended December 31, 2021, indicating a decline of 28.5%[2] - The gross profit for the year ended December 31, 2022, was approximately RMB 159.1 million, a decrease of about 17.4% compared to the previous year[5] - The total revenue across all business segments reached RMB 356.7 million, marking a 10.0% increase from RMB 324.2 million in 2021[14] - The net profit for the year ended December 31, 2022, decreased by approximately 24.7% to RMB 54.2 million, compared to RMB 72.0 million for the year ended December 31, 2021[44] - Profit before tax decreased by approximately 43.0% to RMB 54.5 million for the year ended December 31, 2022, down from RMB 95.5 million for the year ended December 31, 2021, due to a decline in gross profit and increased expenses[42] - Basic and diluted earnings per share for the year were RMB 13.58, down from RMB 21.12 in the previous year[57] Revenue Growth by Segment - Revenue from the Smart Retail Cloud segment grew by 32.4% to RMB 126.5 million in 2022, compared to RMB 95.6 million in 2021[3] - Revenue from Data Insight Solutions increased by 39.6% to RMB 225.3 million in 2022, up from RMB 161.4 million in 2021[3] - The Smart Decision Cloud generated RMB 182.7 million in revenue for the fiscal year ending December 31, 2022, a decrease of 9.9% compared to RMB 202.7 million in 2021[14] - The Smart Health Management Cloud achieved remarkable growth of 2,718.6%, with revenue increasing to RMB 10.5 million from RMB 371, compared to the previous year[14] - The Smart Medical Cloud generated RMB 37.0 million in revenue, a 45.2% increase from RMB 25.5 million in 2021[14] Market Expansion and Strategy - The company plans to enhance its digital transformation and market expansion strategies to meet the increasing demand for health industry digitalization[5] - The company aims to leverage its data-driven capabilities to address the urgent needs of medical product suppliers for efficiency and cost reduction in the coming year[5] - The company aims to establish a closed-loop database encompassing patients, pharmacies, hospitals, and health check services to maximize data value and enter the commercial insurance and life sciences sectors[30] - The company plans to develop two new business segments: Smart Clinic Cloud and Smart Insurance Cloud, to enhance its strategic layout in health management[12] - The company is focused on enhancing product quality and professional service capabilities to provide diversified digital applications and solutions in the health industry[34] Operational Metrics - The number of cooperative pharmacies increased by 14.3% to 1,225 in 2022, up from 1,072 in 2021[4] - The number of consumers managed through SIC by pharmacies reached approximately 273,533, a 35.5% increase from 201,840 in 2021[4] - The number of retail stores covered by Smart Retail Cloud's SIC product exceeded 58,000, representing a year-on-year growth of approximately 33.5%[15] - The number of enterprise clients for Smart Decision Cloud increased by approximately 26.0% to 576 clients by the end of 2022[17] - The total data stored and analyzed exceeded 30TB, representing a nearly 50% increase compared to 2021[23] Expenses and Cost Management - Sales costs rose by approximately 50.2%, from RMB 131.5 million in 2021 to RMB 197.6 million in 2022, mainly due to business growth[36] - Gross profit decreased by approximately 17.4% from RMB 192.6 million in 2021 to RMB 159.1 million in 2022, resulting in a gross margin decline from 59.4% to 44.6%[37] - Selling and distribution expenses increased by approximately 27.7% to RMB 31.7 million for the year ended December 31, 2022, up from RMB 24.8 million for the year ended December 31, 2021, mainly due to an increase in the number of sales and marketing employees[39] - Administrative expenses rose by approximately 4.4% to RMB 46.1 million for the year ended December 31, 2022, from RMB 44.2 million for the year ended December 31, 2021, primarily due to increased employee benefits and professional fees[40] - Research and development costs increased by approximately 12.5% to RMB 60.4 million for the year ended December 31, 2022, from RMB 53.7 million for the year ended December 31, 2021, mainly due to higher employee benefits[41] Cash Flow and Financial Position - Cash and cash equivalents totaled approximately RMB 409.3 million as of December 31, 2022, representing an increase of approximately 1,105.5% from the previous year, primarily due to net proceeds from the global offering[48] - The debt-to-asset ratio as of December 31, 2022, was 14.9%, down from 24.3% as of December 31, 2021[50] - Total assets as of December 31, 2022, amounted to RMB 698,684,000, an increase from RMB 420,885,000 in 2021, showing a growth of approximately 66%[59] - The company's total equity increased to RMB 693,236,000 in 2022 from RMB 415,911,000 in 2021, representing a growth of about 67%[60] Employee and Governance - The total number of full-time employees increased to 680 as of December 31, 2022, from 624 as of December 31, 2021, with employee costs rising by approximately 12.8% to RMB 145.9 million[54] - The company emphasizes diversity and equal opportunity in its hiring process and invests in employee development through training programs[55] - The company has implemented stock option and share award plans to incentivize qualified individuals contributing to its interests[56] - The audit committee consists of three independent non-executive directors, ensuring proper oversight and governance[105] Future Outlook - The company anticipates a rapid recovery in business activities as the impact of COVID-19 diminishes and industry activities return to normal[15][17] - The smart insurance cloud is projected to grow rapidly, leveraging medical and health check data to create a comprehensive health management service for commercial insurance[34] - The company is committed to continuous product and service iteration to meet the high-quality development needs of the industry[28] - The company plans to continue utilizing the net proceeds as outlined in the prospectus without significant changes or delays[101]
中康控股(02361) - 2022 - 年度业绩